MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • XML
    92.23 Kb
  • PDF
    201.17 Kb
  • HTML
    64.77 Kb
Add to My Favorites
You must be logged in to use this functionality
Loading full text...

Full text loading...

1. Abernathy, T. J.,, and O. T. Avery. 1941. The occurrence of a protein not normally present in the blood. I. Distribution of the reactive protein in patients’ sera and the effect of calcium on the flocculation reaction with C polysaccharide. J. Exp. Med. 73:173182.
2. Austrian, R. 1953. Morphologic variation in pneumococcus. I. An analysis of the bases for morphologic variation in pneumococcus and description of a hitherto undefined morphologic variant. J. Exp. Med. 98:2134.
3. Austrian, R. 1977. Of gold and pneumococci. Trans. Am. Clin. Climatol. Assoc. 89: 141161.
4. Austrian, R. 1960. The Gram stain and the etiology of lobar pneumonia, an historical note. Bacteriol. Rev. 24:261265.
5. Austrian, R. 1981. Pneumococcus: the first one hundred years. Rev. Infect. Dis. 3:183189.
6. Austrian, R. 1986. Some aspects of the pneumococcal carrier state. J. Antimicrob. Chemother. 18 (Suppl. A):3545.
7. Austrian, R.,, R. M. Douglas,, G. Schiffman,, A. M. Coetzee,, H. J. Koornhof,, S. Hayden-Smith,, and R. D. W. Reid. 1976. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Phys. 89:184194.
8. Austrian, R.,, and J. Gold. 1964. Pneumococcal bacteremia with a special reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60:759776.
9. Avery, O. T.,, H. T. Chickering,, R. Cole,, and A. R. Dochez. 1917. Acute lobar pneumonia. Prevention and treatment. Rockefeller Institute for Medical Research monograph 7, p. 1100. The Rockfeller Institute for Medical Research, New York, N.Y.
10. Avery, O. T.,, and R. Dubos. 1930. The specific action of a bacterial enzyme on pneumococci of type III. Science 72:151152.
11. Avery, O. T.,, and R. Dubos. 1931. The protective action of a specific enzyme against type III pneumococcus infection in mice. J. Exp. Med. 54:7389.
12. Avery, O. T.,, and W. F. Goebel. 1931. Chemo-immunological studies on conjugated carbohydrate proteins. V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with a foreign protein. J. Exp. Med. 54:437447.
13. Avery, O. T.,, C. M. MacLeod,, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction from pneumococcus type 3. J. Exp. Med. 79:137158.
14. Bezançon, F.,, and V. Griffin. 1897. Pouvoir agglutinatif du serum dans les infections expérimentales et humaines, à pneumocoques. C. R. Soc. Biol. 48:579581.
15. Black, S.,, H. Shinefield,, B. Firman,, E. Lewis,, P. Ray,, J. R. Hansen,, L. Elvin,, K. M. Ensor,, J. Hackell,, G. Siber,, F. Malinoski,, D. Madore,, I. Chang,, R. Kohberger,, W. Watson,, R. Austrian,, K. Edwards, and the Northern California Permanente Vaccine Group. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19:187195.
16. Bornstein, D. L.,, G. Schiffman,, H. P. Bernheimer,, and R. Austrian. 1968. Capsulation of pneumococci with soluble C-like (Cs) polysaccharide. J. Exp. Med. 128:13851400.
17. Boulnois, G. J. 1992. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J. Gen. Microbiol. 138:249259.
18. Bowers, E. F.,, and L. R. Jeffries. 1955. Optochin in the identification of Str. pneumoniae. J. Clin. Pathol. 8:5860.
19. Briles, D. E.,, R. C. Tart,, E. Swiatlo,, J. P. Dillard,, P. Smith,, K. A. Benton,, B. A. Ralph,, A. Brooks-Walter,, M. J. Crain,, S. K. Hollingshead,, and L. S. Mc- Daniel. 1998. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:645657.
20. Chargaff, E. 1951. Structure and function of nucleic acids as cell constituents. Fed. Proc. 10:654659.
21. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885891.
22. Cooper, G.,, C. Rosenstein,, A. Walter,, and L. Peizer. 1932. The further separation of types among the types of pneumococci hitherto included in Group IV and the development of therapeutic antisera for these types. J. Exp. Med. 55:531554.
23. Davies, J. A. V. 1937. The response of infants to inoculation with type 1 pneumococcus carbohydrate. J. Immunol. 33:17.
24. Dawson, M. H. 1928. Interconvertability of “R” and “S” forms of pneumococcus. J. Exp. Med. 47:577591.
25. Dochez, A. R.,, and O. T. Avery. 1917. Soluble substance of pneumococcal origin in the blood and urine during lobar pneumonia. Proc. Soc. Exp. Biol. Med. 14:126127.
26. Dochez, A. R.,, and O. T. Avery. 1917. The elaboration of specific soluble substance by pneumococcus during growth. J. Exp. Med. 26:477493.
27. Ekwurzel, G. M.,, J. S. Simmons,, L. I. Dublin,, and L. D. Felton. 1938. Studies on immunizing substances in pneumococci. VIII. Report on field tests to determine the prophylactic value of a pneumococcus antigen. Public Health Rep. 53:18771893.
28. Felton, L. D. 1928. The units of protective antibody in antipneumococcus serum and antibody solution. J. Infect. Dis. 43:531542.
29. Finland, M.,, and H. F. Dowling. 1935. Cutaneous reactions and antibody response of human subjects to intracutaneous injections of pneumococcus polysaccharides. J. Immunol. 29:285299.
30. Finland, M.,, and W. D. Sutliff. 1932. Specific cutaneous reactions and circulating antibodies in the course of lobar pneumonia. I. Cases receiving no serum therapy. J. Exp. Med. 54:637652.
31. Fraenkel, A. 1885. Bakteriologische Mittheilungen. Z. Klin. Med. 10:401461.
32. Francis, T. J., Jr.,, and W. S. Tillett. 1930. Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharides. J. Exp. Med. 52:573585.
33. Gamaléia, N. 1888. Sur l’étiologie de la pneumonie fibrineuse chez l’homme. Ann. Inst. Pasteur (Paris) 2:440459.
34. Gram, C. 1884. Ueber die isolierte Färbung der Schizomyceten in Schnitt- und Trokenpräparaten. Fortschr. Med. 2:185189.
35. Griffith, F. 1928. The significance of pneumococcal types. J. Hyg. 27:113159.
36. Gundel, M.,, and F. K. T. Schwarz. 1932. Studien über die Bakterienflora der obern Atmungswege Neugeborner (im Vergleich mit der Mundhöhlenflora der Mutter und des Pflegepersonals) unter besonderer Berüchsichtigung ihrer Bedeutung für das Pneumonieproblem. Z. Hyg. Infektionskr. 113:411436.
37. Gundel, M.,, and G. Okura. 1933. Untersuchungen über das gleichzeitige Vorkommen mehrerer Pneumokokkentypen bei Gesunden und ihrer Bedeutung für die Epidemiologie. Z. Hyg. Infektionskr. 114:678704.
38. Hansman, D.,, H. Glasgow,, J. Sturt,, L. Devitt,, and R. Douglas. 1971. Increased resistance to penicillin of pneumococci isolated from man. N. Engl. J. Med. 284:175177.
39. Harford, C. G.,, and M. Hara. 1950. Pulmonary edema in influenzal pneumonia of the mouse and the relation of fluid in the lung to the inception of pneumococcal pneumonia. J. Exp. Med. 91:245259.
40. Hayes, W. 1966. The discovery of pneumococcal type transformation: an appreciation. J. Hyg. 64:177184.
41. Heffron, R. 1939. Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, p. 446475. The Commonwealth Fund, New York, N.Y.
42. Heffron, R. 1939. Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, p. 888903. The Commonwealth Fund, New York, N.Y.
43. Heidelberger, M.,, and O. T. Avery. 1923. The soluble specific substance of the pneumococcus. J. Exp. Med. 38:7379.
44. Heidelberger, M.,, and F. E. Kendall. 1929. A quantitative study of the precipitin reaction between type III pneumococcus polysaccharide and purified homologous antibody. J. Exp. Med. 50:809823.
45. Heidelberger, M.,, C. M. MacLeod,, S. J. Kaiser,, and B. Robinson. 1946. Antibody formation in volunteers following injection of pneumococci or their typespecific polysaccharides. J. Exp. Med. 83:303320.
46. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:27592762.
47. Hodges, R. G.,, C. M. MacLeod,, and W. G. Bernhard. 1946. Epidemic pneumococcal pneumonia. III. Pneumococcal carrier studies. Am. J. Hyg. 44:207230.
48. Horsefall, F. L.,, K. Goodner,, and C. M. MacLeod. 1938. Antipneumococcus rabbit serum as a therapeutic agent in lobar pneumonia. II. Additional observations in pneumococcus pneumonia of nine different types. N. Y. State J. Med. 38:245255.
49. Issaeff, B. 1893. Contribution à l’étude de l’immunité acquise contre le pneumocoque. Ann. Inst. Pasteur (Paris) 7:260279.
50. Klemperer, G.,, and F. Klemperer. 1891. Versuche über Immunisierung und Heilung bei der Pneumokokkeninfection. Berl. Klin. Wochenschr. 28:833835, 869875.
51. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171196.
52. Knecht, J. C.,, G. Schiffman,, and R. Austrian. 1970. Some biological properties of pneumococcus type 37 and the chemistry of its capsular polysaccharide. J. Exp. Med. 132:475487.
53. Kruse, W.,, and S. Pansini. 1892. Untersuchungen über den Diplococcus pneumoniae und verwandte Streptokokken. Z. Hyg. Infektionskr. 11:279380.
54. Lister, F. S. 1916. An experimental study of prophylactic inoculation against pneumococcal infection in the rabbit and in man. S. Afr. Inst. Med. Res. No. 8:231287.
55. Loda, F. A.,, A. M. Collier,, W. P. Glezen,, K. Strangert,, W. A. Clyde, Jr.,, and F. W. Denny. 1975. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J. Pediatr. 87:10871093.
56. MacLean, I. H.,, K. B. Rogers,, and A. Fleming. 1939. M & B 693 and pneumococci. Lancet i:562568.
57. MacLeod, C. M.,, R. G. Hodges,, M. Heidelberger,, and W. G. Bernhard. 1945. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J. Exp. Med. 82:445465.
58. Marshall, E. K., Jr.,, K. Emerson, Jr.,, and W. C. Cutting. 1937. Para-aminobenzene sulfonamide; absorption and excretion; method of determination in urine and blood. JAMA 108:953957.
59. McCarty, M. 1946. Purification and properties of desoxyribonuclease isolated from beef pancreas. J. Gen. Physiol. 29:123139.
60. McCarty, M. 1985. The Transforming Principle. Discovering That Genes Are Made of DNA, p. 7388. W. W. Norton & Co., New York, N.Y.
61. McCarty, M. 1985. The Transforming Principle. Discovering That Genes Are Made of DNA, p. 213235. W. W. Norton & Co., New York, N.Y.
62. Metchnikoff, E. 1891. Etudes sur l’immunité. IV. L’immunité des cobayes vaccinées contre le Vibrio Metchnikowii. Ann. Inst. Pasteur (Paris) 5:465478.
63. Moore, H. F.,, and A. M. Chesney. 1917. A study of ethylhydrocuprein (optochin) in the treatment of acute lobar pneumonia. Arch. Intern. Med. 19:611682.
64. Moore, H. F.,, and A. M. Chesney. 1918. A further study of ethylhydrocuprein (optochin) in the treatment of acute lobar pneumonia. Arch. Intern. Med. 21:659681.
65. Morgenroth, J.,, and M. Kaufmann. 1912. Arzneifestigkeit bei Bakterien (Pneumokokken). Z. Immunitaetsforsch. Exp. Ther. 15:610624.
66. Morgenroth, J.,, and R. Levy. 1911. Chemotherapie der Pneumokokkeninfektion. Berl. Klin. Wochenschr. 48:15601561, 1979-1983.
67.Netter. 1886. De l’endocardite végétante-ulcéreuse d’origine pneumonique. Arch. Physiol. Norm. Pathol. 8 [Ser. 3]:106161.
68. Neufeld, F. 1900. Ueber eine specifische bacteriolytische Wirkung der Galle. Z. Hyg. Infektionskr. 34:454464.
69. Neufeld, F. 1902. Ueber die Agglutination der Pneumokokken und über die Theorieen der Agglutination. Z. Hyg. Infektionskr. 40:5472.
70. Neufeld, F.,, and R. Etinger-Tulczynska. 1932. Nasale Pneumokokkeninfectionen and Pneumokokkenkeimtrager im Tierversuch. Z. Hyg. Infektionskr. 112:492526.
71. Neufeld, F., and Händel. 1910. Weitere Untersuchungen über Pneumokokken Heilsera. III. Mitteilung. Über Vorkommenen und Bedeutung atypischer Varietäten des Pneumokokkus. Arb. Kaiserlichen Gesundheitsamte 34:293304.
72. Neufeld, F.,, and W. Levinthal. 1928. Beiträge zur Variabilität der Pneumokokken. Z. Immunitaetsforsch. Exp. Ther. 55:324340.
73. Neufeld, F.,, and W. Rimpau. 1904. Ueber die Antikörper des Streptokokken und Pneumokokken—Immunserums. Dtsch. Med. Wochenschr. 30:14581460.
74. Novak, R.,, B. Henriques,, E. Charpentier,, S. Normark,, and E. Tuomanen. 1999. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 399:590593.
75. Osler, W. 1897. On certain features in the prognosis of pneumonia. Am. J. Med. Sci. 113:110.
76.Pasteur. 1881. Note sur la maladie nouvelle provoquée par la salive d’un enfant mort de la rage. Bull. Acad. Med. (Paris) 10:94103.
77. Rich, A. R.,, and C. M. McKee. 1939. The pathogenicity of avirulent pneumococci for animals deprived of leukocytes. Bull. Johns Hopkins Hosp. 64:434446.
78. Robbins, J. B.,, R. Schneerson,, P. Anderson,, and D. H. Smith. 1996. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. JAMA 276:11811185.
79. Schiemann, O.,, and W. Casper. 1927. Sind die spezifisch präcipitablen Subtanzen der 3 Pneumokokkentypen Haptene? Z. Hyg. Infektionskr. 108:220257.
80. Schmidt, L. H.,, and C. L. Sessler. 1943. Development of resistance to penicillin by pneumococci. Proc. Soc. Exp. Biol. Med. 52:353357.
81. Shapiro, E. D.,, A. T. Berg,, R. Austrian,, D. Schroeder,, V. Parcells,, A. Margolis,, R. K. Adair,, and J. D. Clemens. 1991. The protective efficacy of pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:14531460.
82. Sternberg, G. M. 1881. A fatal form of septicaemia in the rabbit, produced by subcutaneous injection of human saliva. An experimental research. Natl. Board Health Bull. 2:781783.
83. Sternberg, G. M. 1882. A fatal form of septicaemia in the rabbit, produced by the subcutaneous injection of human saliva. Studies Biol. Lab. Johns Hopkins Univ. 2:183200.
84. Sternberg, G. M. 1882. Induced septicaemia in the rabbit. Am. J. Med. Sci. 84: 6976.
85. Stryker, L. M. 1916. Variations in the pneumococcus induced by growth in immune serum. J. Exp. Med. 24:4968.
86. Tettelin, H.,, K. E. Nelson,, S. Peterson,, J. A. Eisen,, T. D. Read,, R. T. DeBoy,, D. H. Haft,, R. J. Dodson,, A. Scott Durkin,, M. Gwinn,, J. F. Kolonay,, W. C. Nelson,, J. D. Peterson,, L. A. Umayam,, O. White,, S. L. Salzberg,, M. R. Lewis,, D. Radune,, E. Holtzapple,, H. Khouri,, A. M. Wolf,, T. R. Utterback,, S. Angiuoli,, T. Dickinson,, E. K. Hickey,, I. E. Holt,, B. J. Loftus,, F. Yang,, H. O. Smith,, J. C. Venter,, B. A. Dougherty,, D. A. Morrison,, S. Hillingshead,, and C. M. Fraser. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498506.
87. Tillett, W. S.,, and T. Francis, Jr. 1930. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J. Exp. Med. 52:561571.
88. Tugendreich, J.,, and C. Russo. 1913. Ueber die Wirkung von Chinaalkaloiden auf Pneumokokkenkulturen. Z. Immunitaetsforsch. Exp. Ther. 19:156171.
89. Watson, J. D.,, and F. H. C. Crick. 1953. The structure of DNA. Cold Spring Harbor Symp. Quant. Biol. 18:123131.
90. Watson, J. D.,, M. Gilman,, J. Witkowski,, and M. Zoller. 1992. Recombinant DNA, 2nd ed. Scientific American Books, New York, N.Y.
91. Webster, L. T.,, and T. P. Hughes. 1931. The epidemiology of pneumococcus infection. J. Exp. Med. 53:535552.
92. Weiser, J. N.,, R. Austrian,, P. K. Sreenviasan,, and H. R. Masure. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasal colonization. Infect. Immun. 62:25822589.
93. Welch, W. H. 1892. The micrococcus lanceolatus, with a special reference to the etiology of acute lobar pneumonia. Bull. Johns Hopkins Hosp. 3:125139.
94. White, B. 1938. The Biology of Pneumococcus, p. XVIXVII. The Commonwealth Fund, New York, N.Y.
95. Wright, A. E.,, W. Parry Morgan,, L. Colebrook,, and R. W. Dodgson. 1914. Observations on prophylactic inoculation against pneumococcus infections, and on the results which have been achieved by it. Lancet i:110, 8795.
96. Zighelboim, S.,, and A. Tomasz. 1980. Penicillin-binding proteins of multiply antibiotic resistant South African strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:434442.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error